Henagliflozin

<!-- Clinical data --> Henagliflozin is a pharmaceutical drug for the treatment of type 2 diabetes. In China, it is approved for adult patients with type 2 diabetes to improve the glycemic control.

Henagliflozin, like other drugs of the gliflozin class, inhibits the transporter protein sodium/glucose cotransporter 2 (SGLT2) which leads to a reduction in blood glucose levels. Provided by Wikipedia

Search Results

Showing 1 - 2 results of 2 for search 'Rui Qin', query time: 0.01s Refine Results
  1. 1
    by Qiang Han, Zhiguo Wang, Rui Qin
    Published in Geofluids (2022)
    Get access
    Get access
    Article in Journal/Newspaper
  2. 2
    Get access
    Get access
    Get access
    Text
Search Tools: Get RSS Feed